1Clinique de l'Hypertension, Hôpital Erasme, Bruxelles.
Losartan, an angiotensin II receptor inhibitor, is reviewed for its clinical value and cost-effectiveness. This drug offers significant benefits in patient care and economic considerations.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: